US April Payrolls Surge Past Forecasts Yet Underlying Concerns Linger Greencore FirstHalf Profits Weighed Down by Bakkavor Acquisition Costs Elon Musks OpenAI Attack Seen as Strategic Move to Clear Runway for xAI According to Analyst Genpact CEO Warns AI Will Cut IT Workloads and Reduce Hiring Growth in India Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions Tempus AI and Bristol Myers Squibb Announce Strategic Collaboration to Advance Clinical Trials Trinity Capital Inc TRINI Q1 2026 Earnings EPS Beat Sends Modest Signal in Steady Quarter Vertex Inc VERX Q1 2026 Earnings EPS Beat Drives Modest Share Gains Revenue Unreported SENEA Q1 2026 Earnings Strong EPS of 619 Reported Amid Quiet Market Reaction CBUS Q1 2026 Earnings Results Beat Estimates with Narrowed Loss Stock Rises 29 TCBX Q1 2026 Earnings Earnings Per Share Surpasses Estimates Stock Edges Slightly Lower KYIV Q1 2026 Earnings EPS Surpasses Estimates Amid Challenging Macro Environment Scage Future SCAG Surges 834 Testing Key Resistance at 057 Gladstone Commercial Preferred GOODO Holds Steady Near 2023 as Yield Attracts Investors Douglas Dynamics PLOW Gains 174 as Winter Weather Outlook Supports Demand Elanco Animal Health ELAN Pushes Higher Breaking Past Recent Trading Range PGIM Global High Yield Fund GHY Holds Steady Near Key Technical Levels FBLG Q1 2026 Earnings Narrowly Misses EPS Estimates No Revenue Reported Capital Bancorp Inc Q1 2026 Earnings Earnings Miss Expectations Shares Edge Higher Westwater Resources Inc WWR Q1 2026 Earnings Modest EPS Beat as PreRevenue Graphite Developer Advances IMMR Q3 2025 Earnings EPS Beats Estimates by 1878 Stock Rises BATL Q2 2023 Earnings NarrowerThanExpected Loss Fails to Lift Shares PRS Q1 2026 Earnings Robust EPS Beat of 154 Highlights Operational Strength Amid Stable FixedIncome Performance Banks Closed on Memorial Day A Guide to 12 Federal Holidays Impacting Banking Services ARCO Q1 2026 Earnings Profit Surges Past Estimates on Operational Strength Yet Shares Slide Collegium Pharmaceutical COLL Nears Key Support After Modest Decline